Stage IIIB Cutaneous Melanoma AJCC v7 Completed Phase 2 Trials for Fludarabine (DB01073)

Indication	Status	Phase
DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01807182	Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma	Treatment	Aldesleukin (DB00041) Cyclophosphamide (DB00531) Fludarabine (DB01073)